Posted by Michael Wonder on 16 Mar 2021
ATAGI statement in response to European decisions about the AstraZeneca vaccine
16 March 2021 - ATAGI notes the suspension of the AstraZeneca vaccine program in several European countries due to reports of a potential link with thrombotic events.
Based on evidence to date, ATAGI do not see any reason to pause use of the AstraZeneca vaccine in Australia.
